Naspers (NPSNY)
(Delayed Data from OTC)
$75.34 USD
+1.13 (1.52%)
Updated Oct 3, 2025 03:53 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NPSNY 75.34 +1.13(1.52%)
Will NPSNY be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for NPSNY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NPSNY
Zacks Industry Outlook Highlights Comcast, Charter Communications and Naspers
3 Stocks to Watch From a Challenging Cable Television Industry
NPSNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Laureate Education (LAUR) Outperforming Other Consumer Discretionary Stocks This Year?
TakeTwo's Q4 Loss Widens Year Over Year, Revenues Increase
Naspers (NPSNY) Is a Great Choice for 'Trend' Investors, Here's Why
Other News for NPSNY
Thornburg Developing World Fund Q2 2025 Commentary
Macquarie Emerging Markets Fund Q2 2025 Commentary
Davis Global Fund 2025 Semi-Annual Review